TY - JOUR
T1 - Evaluation and preoperative management of lung volume reduction surgery candidates
AU - Yusen, R. D.
AU - Lefrak, S. S.
AU - Trulock, E. P.
N1 - Funding Information:
Supported, in part, by NIH-National Heart, Lung, and Blood Institute Grant HL07317, the Norman P. Knowlton, Jr., MD, Incentive for Excellence Fund of Barnes-Jewish Hospital, and the Dr. N. Drey Emphysema Fund.
PY - 1997
Y1 - 1997
N2 - The efficacy of lung volume reduction surgery has been demonstrated by improvements in functional status, dyspnea, pulmonary function, alveolar gas exchange, and exercise tolerance. However, surgery has a significant morbidity, mortality, and cost. Surgical outcome is dependent on the clinical, anatomical, and physiological features of the patients and their emphysema. Therefore, the patient evaluation process and the preoperative optimization of medical therapy are crucial for success. Though understanding mechanisms for improvement have added insight to the selection process, patient selection needs further clarification.
AB - The efficacy of lung volume reduction surgery has been demonstrated by improvements in functional status, dyspnea, pulmonary function, alveolar gas exchange, and exercise tolerance. However, surgery has a significant morbidity, mortality, and cost. Surgical outcome is dependent on the clinical, anatomical, and physiological features of the patients and their emphysema. Therefore, the patient evaluation process and the preoperative optimization of medical therapy are crucial for success. Though understanding mechanisms for improvement have added insight to the selection process, patient selection needs further clarification.
UR - http://www.scopus.com/inward/record.url?scp=0030975822&partnerID=8YFLogxK
U2 - 10.1016/S0272-5231(05)70372-5
DO - 10.1016/S0272-5231(05)70372-5
M3 - Article
C2 - 9187815
AN - SCOPUS:0030975822
SN - 0272-5231
VL - 18
SP - 199
EP - 224
JO - Clinics in Chest Medicine
JF - Clinics in Chest Medicine
IS - 2
ER -